No Mortality Signal With Stellarex Low-Dose Paclitaxel DCB: ILLUMENATE Pivotal 4-Year Outcomes.

Saved in:
Bibliographic Details
Title: No Mortality Signal With Stellarex Low-Dose Paclitaxel DCB: ILLUMENATE Pivotal 4-Year Outcomes.
Authors: Lyden SP; Department of Vascular Surgery, Cleveland Clinic, Cleveland, OH, USA., Faries PL; Division of Vascular Surgery, The Mount Sinai Hospital, New York, NY, USA., Niazi KAK; Division of Cardiology, Emory University, Atlanta, GA, USA., Sachar R; North Carolina Heart and Vascular Services, UNC REX Healthcare, Raleigh, NC, USA., Jain A; Mission Cardiovascular Research Institute, Fremont, CA, USA., Brodmann M; Division of Angiology, Medical University of Graz, Graz, Austria., Werner M; Department of Angiology, Hanusch Hospital, Vienna, Austria., Sood A; Philips North America LLC, Cambridge, MA, USA., Krishnan P; Cardiovascular Institute, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Source: Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists [J Endovasc Ther] 2022 Dec; Vol. 29 (6), pp. 929-936. Date of Electronic Publication: 2022 Jan 08.
Publication Type: Randomized Controlled Trial; Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Sage Publications Country of Publication: United States NLM ID: 100896915 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-1550 (Electronic) Linking ISSN: 15266028 NLM ISO Abbreviation: J Endovasc Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1545-1550
DOI:10.1177/15266028211068769